Kevin Smith’s ‘The 4:30 Movie’ is Both Sweet-Natured and Tacky. A semi-autographical coming-of-age ...

Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call. On today's call are Thomas Meyer, Altamira's Founder, Chairman and Chief Executive Officer; ...

Operator: Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

(“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today provided a business update ...

(“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today provided a business update and reported ...

$4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants H.C. Wainwright & Co. is acting as the exclusive ...

New Fortress Energy's shares rally as it addresses debt and raises $400 million in an equity offering, but dilution may ...